Newz Via
HomebusinessLiveMint-Business

Zydus launches cancer biosimilar nivolumab at steep discount

Author

By LiveMint-Business

Zydus launches cancer biosimilar nivolumab at steep discount
Representative Image • Source: LiveMint-Business
The launch follows a Delhi High Court nod allowing sales of the cancer drug biosimilar ahead of patent expiry in May 2026.

More from Categories

Business

View All

Technology

View All

Sports

View All